Oncogene - Table of Contents alert Volume 34 Issue 22

If you are unable to see the message below, click here to view.

Advertisement New! Transcription factor ChIP-seq with complete ease iDeal ChIP-seq Kit for Transcription Factors Start-to-finish ChIP including control antibodies such as CTCF and primers. Tackles the toughest transcription factor ChIPs and validated with multiple TFs including HDAC1, LSD1, p53, P300, HDAC2, EZH2, and many more. Learn more. TABLE OF CONTENTS Volume 34, Issue 22 (May 2015) In this issue Review Original Articles Short Communications Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Nature Genetics in association with the Wellcome Trust present: The Genomics of Common Diseases 2015 September 2-5, 2015 | Cambridge, UK Register now! Review Top DNA damage response and prostate cancer: defects, regulation and therapeutic implications S Karanika, T Karantanos, L Li, P G Corn and T C Thompson Oncogene 2015 34: 2815-2822; advance online publication, August 18, 2014; 10.1038/onc.2014.238 Abstract | Full Text Original Articles Top Thrombospondin-1 repression is mediated via distinct mechanisms in fibroblasts and epithelial cells R S Watnick, R K Rodriguez, S Wang, A L Blois, A Rangarajan, T Ince and R A Weinberg Oncogene 2015 34: 2823-2835; advance online publication, August 11, 2014; 10.1038/onc.2014.228 Abstract | Full Text TRIM24 links glucose metabolism with transformation of human mammary epithelial cells T N Pathiraja, K N Thakkar, S Jiang, S Stratton, Z Liu, M Gagea, X Shi, P K Shah, L Phan, M-H Lee, J Andersen, M Stampfer and M C Barton Oncogene 2015 34: 2836-2845; advance online publication, July 28, 2014; 10.1038/onc.2014.220 Abstract | Full Text Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2 A Kroiss, S Vincent, M Decaussin-Petrucci, E Meugnier, J Viallet, A Ruffion, F Chalmel, J Samarut and N Allioli Oncogene 2015 34: 2846-2855; advance online publication, July 28, 2014; 10.1038/onc.2014.222 Abstract | Full Text Lineage-specific RUNX3 hypomethylation marks the preneoplastic immune component of gastric cancer B Kurklu, R H Whitehead, E K Ong, T Minamoto, J G Fox, J R Mann, L M Judd, A S Giraud and T R Menheniott Oncogene 2015 34: 2856-2866; advance online publication, August 4, 2014; 10.1038/onc.2014.233 Abstract | Full Text K63-linked ubiquitination of FANCG is required for its association with the Rap80-BRCA1 complex to modulate homologous recombination repair of DNA interstand crosslinks B Zhu, K Yan, L Li, M Lin, S Zhang, Q He, D Zheng, H Yang and G Shao Oncogene 2015 34: 2867-2878; advance online publication, August 18, 2014; 10.1038/onc.2014.229 Abstract | Full Text Melanoma susceptibility as a complex trait: genetic variation controls all stages of tumor progression B Ferguson, R Ram, H Y Handoko, P Mukhopadhyay, H K Muller, H P Soyer, G Morahan and G J Walker Oncogene 2015 34: 2879-2886; advance online publication, August 4, 2014; 10.1038/onc.2014.227 Abstract | Full Text Differential response of normal and malignant urothelial cells to CHK1 and ATM inhibitors W-T Wang, J W F Catto and M Meuth Oncogene 2015 34: 2887-2896; advance online publication, July 21, 2014; 10.1038/onc.2014.221 Abstract | Full Text PHF2 histone demethylase acts as a tumor suppressor in association with p53 in cancer K-H Lee, J-W Park, H-S Sung, Y-J Choi, W H Kim, H S Lee, H-J Chung, H-W Shin, C-H Cho, T-Y Kim, S-H Li, H-D Youn, S J Kim and Y-S Chun Oncogene 2015 34: 2897-2909; advance online publication, July 21, 2014; 10.1038/onc.2014.219 Abstract | Full Text Gα12 gep oncogene deregulation of p53-responsive microRNAs promotes epithelial–mesenchymal transition of hepatocellular carcinoma Y M Yang, W H Lee, C G Lee, J An, E-S Kim, S H Kim, S-K Lee, C H Lee, D N Dhanasekaran, A Moon, S Hwang, S J Lee, J-W Park, K M Kim and S G Kim Oncogene 2015 34: 2910-2921; advance online publication, July 28, 2014; 10.1038/onc.2014.218 Abstract | Full Text Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo P W M Ho, A Goradia, M R Russell, A M Chalk, K M Milley, E K Baker, J A Danks, J L Slavin, M Walia, B Crimeen-Irwin, R A Dickins, T J Martin and C R Walkley Oncogene 2015 34: 2922-2933; advance online publication, July 21, 2014; 10.1038/onc.2014.217 Abstract | Full Text Short Communications Top The p38-MK2-HuR pathway potentiates EGFRvIII–IL-1β-driven IL-6 secretion in glioblastoma cells F M S Gurgis, Y T Yeung, M X M Tang, B Heng, M Buckland, A J nbsp;Ammit, J Haapasalo, H Haapasalo, G J Guillemin, T Grewal and L Munoz Oncogene 2015 34: 2934-2942; advance online publication, August 4, 2014; 10.1038/onc.2014.225 Abstract | Full Text Mice engineered for an obligatory Mdm4 exon skipping express higher levels of the Mdm4-S isoform but exhibit increased p53 activity B Bardot, R Bouarich-Bourimi, J Leemput, V Lejour, A Hamon, L Plancke, A G Jochemsen, I Simeonova, M Fang and F Toledo Oncogene 2015 34: 2943-2948; advance online publication, August 4, 2014; 10.1038/onc.2014.230 Abstract | Full Text Corrigendum Top Thrombospondin-1 repression is mediated via distinct mechanisms in fibroblasts and epithelial cells R S Watnick, R K Rodriguez, S Wang, A L Blois, A Rangarajan, T Ince and R A Weinberg Oncogene 2015 34: 2949-2950; 10.1038/onc.2015.183 Full Text Advertisement A new open access, online-only journal dedicated to publishing the highest quality research into ways to help the human body repair, replace, restore and regenerate damaged tissues and organs. Published by Nature Publishing Group in partnership with the Australian Regenerative Medicine Institute (ARMI) at Monash University.  Find out more Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.